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Al(OH)3 facilitated synthesis of water-soluble,
magnetic, radiolabelled and fluorescent
hydroxyapatite nanoparticles†
X. Cui,‡a M. A. Green,*ab P. J. Blower,*a D. Zhou,c Y. Yan,d W. Zhang,e
K. Djanashvili,e D. Mathe,f D. S. Veresg and K. Szigetig
Magnetic and fluorescent hydroxyapatite nanoparticles were synthe-
sised using Al(OH)3-stabilised MnFe2O4 or Fe3O4 nanoparticles as
precursors. They were readily and efficiently radiolabelled with 18F.
Bisphosphonate polyethylene glycol polymers were utilised to
endow the nanoparticles with excellent colloidal stability in water
and to incorporate cyclam for high affinity labelling with 64Cu.
Molecular imaging techniques, including magnetic resonance
imaging (MRI), positron emission tomography (PET), single photon
emission computed tomography (SPECT) and fluorescence optical
imaging, play an increasingly important role in clinical diagnosis
and management of disease, as well as medical and biological
research. Multimodal imaging recently has gained attention
because of its potential to overcome the limitations of individual
imaging modalities and to provide more accurate and complete
physiological information at sites of disease.1–3 Numerous nano-
particles (NPs) have been studied as multimodal imaging contrast
agents due to their multi-functionality and potential for surface
modification.4–7 An adequate multimodal nanoparticulate contrast
agent must be multifunctional, biocompatible and colloidally
stable. The NPs should be uniform in morphology and size,
so that they share similar in vivo behaviour, and chemically
stable to ensure that the signal of each modality reflects the
same anatomic position.
Hydroxyapatite (HA) has attracted much interest as the basis of
multifunctional probes very recently,8–11 because of its biocompat-
ibility and high affinity for fluoride which allows facile labelling with
the positron emitter 18F. Fluorescent HA can be obtained by either
doping with rare earth cations8,11 or by conjugation with organic
dyes.10 HA is not an ideal fluorescent host matrix, so luminescent
rare earth dopedHA nanocrystal requires up to 20% replacement of
OH by F (maximum theoretical value for fluoride substitution),
to minimise the quenching of the excited sate of rare earth
cations.8,12,13 As a result, such HA is no longer suitable for 18F
radiolabelling. It has been reported that magnetic iron oxide NPs
can be deposited on the surface of HA aggregates or NPs via
thermolysis11 or a wet chemistry approach.9 One problem that
remained unsolved for both synthetic approaches is how to
effectively isolate the desired Fe3O4–HA composites from the
unwanted iron oxides and HA nanoparticles. Moreover, all these
multifunctional HA NPs suffer from the problem of aggregation or
large size to some extent, which is an obstacle for their biological
or medical applications. In this work, we present a novel synthesis
of magnetic and fluorescent HA nanocomposites with uniform
size and morphology, and excellent colloidal stability in water by
using Fe3O4 nanoparticles stabilised with Al(OH)3 as a template.
The radiolabelling, magnetic and optical properties were investi-
gated, to demonstrate potential for application as tri-modal
probes for MR, PET and optical imaging.
Our strategy is to synthesise HA using water-soluble magnetic
Fe3O4@Al(OH)3 or MnFe2O4@Al(OH)3 NPs as templates. The advan-
tages of this approach is the small hydrodynamic size of the
template particles and their excellent colloidal stability, provided
by the Al(OH)3 layer as reported previously.
14 More importantly, the
layer of Al(OH)3 can be readily removed as it is soluble under basic
pH conditions. The design incorporated bisphosphonate poly-
ethylene glycol (BP-PEG) polymers (Scheme 1) to stabilise NPs
after the formation of HA on the surface, to take advantage of the
outstanding binding affinity of bisphosphonates to HA.
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Bisphosphonate amine 1 was obtained via a slightly modified
version of the previously reported protocol.15 PEG carboxylic acids
were obtained by oxidation of corresponding PEG polymers with
CrO3/H2SO4 via the reported protocol.
16 The bisphosphonate (BP)
or 1,4,8,11-tetraazacyclotetradecane (cyclam) were grafted to PEG
polymeric chain via amide formation mediated by N,N0-dicyclo-
hexylcarbodiimide (DCC), followed by deprotection with bromo-
trimethylsilane (TMBS).17 BP-PEG-Me 2 and BP-PEG-cyclam 3
were purified by dialysis for over 24 hours using a membrane
with a cut-off size of 3500 Da to remove unconjugated small
molecules such as bisphosphonate amine 1 and 1,4,8,11-tetra-
azacyclotetradecane. The conjugation of bisphosphonate and PEG
was confirmed by the change in chemical shift in the 31P NMR
spectrum (from 20 ppm for free bisphosphonate to 12.8 ppm for
BP-PEG, see ESI†).
Nanoparticulate precursors MnFe2O4@Al(OH)3 and Fe3O4@
Al(OH)3 were obtained via a method reported by our group
previously.14 Typically, 4 ml Fe3O4@Al(OH)3 colloids (concentration
of Fe3O4, ca. 8 mg ml
1) and 200 mg BP-PEG-Me polymers 2 were
placed in a 500 ml flask containing 300 ml water. Under stirring,
4 ml 0.1 mol l1 NaH2PO4 and 4 ml 0.2 mol l
1 CaCl2 aqueous
solutions were added sequentially. This light brown solution was
refluxed overnight after the addition of 30 ml 28% ammonia water.
The NPs were collected by centrifugation at 2000 g for 30 minutes,
re-dissolved in 10 ml water and freeze dried.
The X-ray powder diffraction (XRD) pattern of NPs indicates
co-existence of HA and Fe3O4 (or MnFe2O4). TEM images show
an olive-like morphology for Fe3O4@HA and MnFe2O4@HA NPs,
which is significantly different both in size and in morphology
from pure HA NPs synthesised under the same conditions (Fig. 1).
Particle analysis by TEM gave amean size of 60.3 nm (major axis)
29.7 nm (minor axis) for Fe3O4@HA NPs (Fig. 1c and d).
MnFe2O4@HA NPs displayed a similar aspect ratio to Fe3O4@HA
NPs, but the size was almost doubled. These results indicate an
important role of BP-PEG-Me in reducing particle size.
The hydrodynamic size of NPs during the synthesis was mon-
itored by dynamic light scattering (DLS) experiments. No obvious
change was observed after adding the solutions of NaH2PO4 and
CaCl2 into the solution of Fe3O4@Al(OH)3 NPs, and it remained
around 80 nm. This leads to a hypothesis that phosphate anions
adsorb on the highly positive charged surface of Fe3O4@Al(OH)3 NP
and then react with the subsequently added Ca2+ to form calcium
phosphate around the NPs. At the elevated temperature and basic
solution environment, the outer layer of calcium phosphate was
converted to crystallised HA, meanwhile the Al(OH)3 was dissolved,
resulting in the formation of Fe3O4@HA NPs. The diminished peak
due to –OH around 3300–3500 cm1 in the IR spectrum, together
with XRD patterns, confirm the replacement of Al(OH)3 layer
by HA. The changes in surface potential of NPs could not be
monitored by measuring the zeta potential during the process,
since the polymeric PEG imposes a thick hydration layer on NP
surface and zeta potential no longer correlates to the surface
potential. Therefore the surface potential was monitored in the
absence of BP-PEG-Me, and a significant decrease in zeta potential
was observed after the addition of NaH2PO4 solution, from 42.5 mV
to 24.9 mV. This is presumed to be due to the adsorption of
phosphate anions on the surface, since the changes in pH should
be negligible in this case. The zeta potential slightly increased back
to 27.1 mV after adding the CaCl2 solution, indicating a reaction
of calcium cations and phosphate anions. Similar results were
also observed for MnFe2O4@HA NPs. In this synthesis approach,
the positively charged Al(OH)3 layer is essential for the formation
of MnFe2O4@HA or Fe3O4@HA. Using the MnFe2O4 NPs colloids
instead of MnFe2O4@Al(OH)3 as precursors, a simple mixture of
magnetic MnFe2O4 and non-magnetic HA NPs was obtained,
identifiable as two kinds of NPs with apparently different
morphology and size on TEM images.
Both MnFe2O4@HA and Fe3O4@HA NPs were coated by
BP-PEG-Me polymers 2 during the synthesis, as confirmed by
ca. 18% mass loss on thermogravimetric analysis (TGA). Due to
the strong interactions between the bisphosphonate group of 2
Scheme 1 Synthesis of bisphosphonate PEG, (i) dropwise addition of
POCl3 at 7.5 1C under N2, extract with CH2Cl2/H2O/CH2Cl2 under basic/
acidic/basic conditions; (ii) CrO3/H2SO4, 24 hours; (iii) react with 1 and
N,N0-dicyclohexylcarbodiimide (DCC), CH2Cl2, 18 h then with TMBS,
remove solvent, stir in methanol; (iv) CrO3/H2SO4, 24 hours; (v) react with 1
and DCC, CH2Cl2, 18 hours; (vi) react with 1,4,8,11-tetraazacyclotetradecane
and DCC, CH2Cl2, 18 hours, then with TMBS, remove solvent, stir in methanol
for 2 h.
Fig. 1 TEM images (a) and (b) and size distribution (c) and (d) (major and
minor axis, respectively) of Fe3O4@HA NPs synthesised from Fe3O4@Al(OH)3
in the presence of BP-PEG-Me; (e) TEM image of MnFe2O4@HA NPs
synthesised in absence of BP-PEG-Me 2; (f) TEM image of pure HA NPs.
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and MnFe2O4@HA and Fe3O4@HA NPs,
17,18 both NPs exhibit
long-term colloidal stability in aqueous solution, even in high
ionic strength environment such as PBS. The hydrodynamic
size of Fe3O4@HA and MnFe2O4@HA NPs remained at 50.7 nm
and 60.3 nm, respectively, for over two months (Fig. 2a). The
excellent colloidal stability and small hydrodynamic size of
MnFe2O4@HA and Fe3O4@HA make them potentially suitable
for biological or medical applications.
Unsurprisingly, because of the high affinity of fluoride
for HA,19 both NPs exhibit a high radiolabelling efficiency with
18F-fluoride, up to 88.3  0.5% for 0.3 mg MnFe2O4@HA NPs
and 92.1  0.1% for 0.3 mg Fe3O4@NaYF4 NPs (Fig. 2b).
Labelling and purification was readily achieved in less than
23 min. To provide a means of incorporating the positron emitter
64Cu, the NPs were sonicated in 1 mgml1 BP-PEG-cyclam solution
for 30 minutes to allow replacement of a fraction of BP-PEG-Me
by BP-PEG-cyclam, and free BP-PEG-polymers were removed by
centrifugation before mixing with radioactivity. The resulting par-
ticles showed a high 64Cu radiolabelling efficiency in a short time
(o5 minutes) (Fig. 2b). Both NPs display essentially the magnetic
properties of Fe3O4 or MnFe2O4 NPs and are active on MR images
(Fig. 2c and d). The transverse (r2) and longitudinal (r1) relaxivities
of Fe3O4@HA NPs were measured to be 150.2  3.2 mM1 s1
and 1.9  0.1 mM1 s1, respectively, at 3 T magnetic field. As
expected, the relaxivities of NPs could be improved by altering the
ratio of magnetic component and non-magnetic HA, since r2 is
proportional to the volume fraction of magnetic component.20 For
example, the r2 of MnFe2O4@HA NPs could be dramatically
improved from 105.7  3.5 mM1 s1 to 246.5  15.9 mM1 s1
by doubling the amount of MnFe2O4@Al(OH)3 while keeping the
amount of NaH2PO4 and CaCl2 solutions the same during the
synthesis. High transverse relaxivity of these magnetic hydroxy-
apatite NPs as well as a high ratio of r2/r1 demonstrate their
potential application as T2 contrast agents on MR imaging.
Fluorescent HA is normally produced either by doping with
rare earth cations (Eu or Tb),8,11,21 or by conjugation with organic
dyes.10,22 Here we conjugated the fluorescent dyes Maria blue
and Alexa Fluors covalently to the NPs surface using sodium
pamidronate as an aminobisphosphonate linker (see ESI†). The
amine group of pamidronate is reactive for NHS ester dyes to
form stable amide bonds while its bisphosphonate group inter-
acts strongly with the Ca or Fe at the surface of NPs; dyes are
thus linked to NPs without the risk of leakage. Fluorescent
spectra in Fig. 3 show an emission at 455 nm for the conjugates
of Fe3O4@HA and Maria blue under excitation at 365 nm, and
an emission at 517 nm for the Alexa Fluors 488 conjugates under
excitation at 488 nm. More importantly, the fluorescence of these
conjugated NPs is stable and strong even after being stored at
room temperature for over one month, implying the potential
applications as optical contrast.
In summary, we have presented a facile approach to synthe-
sise magnetic and fluorescent hydroxyapatite nanoparticles with
a well-defined morphology and uniform size, using Al(OH)3-
stabilised Fe3O4 or MnFe2O4 NPs as templates. The change from
the highly positively charged surface and base-solubility of the
Al(OH)3 layer to the neutral or slightly negative zeta potential
and acid solubility of the Fe3O4@HA particles is likely to
offer alternative biological properties. These NPs are promising
candidates for development as tri-modal probes for MR, PET and
optical imaging, since they display excellent colloidal stability
and high radiolabelling efficiency both for 64Cu and for 18F, as
well as fluorescent and magnetic properties. Radiolabelling with
other metallic radioisotopes will also be achievable by replacing
cyclam with corresponding chelators. This synthesis approach
allows us to tune the magnetic properties of particles by altering
the ratio of precursors, without decreasing the radiolabelling
efficiency or fluorescent property. The flexible conjugation method
ensures that dyes with different wavelengths could be selected
for different applications. The synthesis strategy for conjuga-
tion of BP-PEG-cyclam can also be applied to the conjugation of
BP-PEG with peptides or antibodies, leading to the application
in targeted imaging.
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Fig. 2 (a) DLS size distribution of 1 mg ml1 Fe3O4@HA NPs in aqueous
solution; (b) radiolabelling of MnFe2O4@HA and Fe3O4@HA NPs with
18F-
fluoride and 64CuCl2 (the latter after sonicating the particles with BP-PEG-
cyclam); (c) T1 and T2 weighted MR images of the solution containing
Fe3O4@HA NPs, and (d) relaxivities of Fe3O4@HA NPs. Concentration of
iron in the solution was measured by ICP-MS.
Fig. 3 Emission and excitation spectra of aqueous solutions of Fe3O4@HA
conjugates with (a) Maria blue and (b) Alexa Fluors 488.
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